Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;26(2):150-5.
doi: 10.5021/ad.2014.26.2.150. Epub 2014 Apr 30.

Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: split-body clinical trial

Seung Bae Park  1 , Myung Im  1 , Young Lee  1 , Jeung Hoon Lee  1 , Jeongheui Lim  2 , Yong-Ha Park  2 , Young Joon Seo  1
Affiliations

Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: split-body clinical trial

Seung Bae Park et al. Ann Dermatol. 2014 Apr.

Abstract

Background: Atopic dermatitis (AD) patients suffer from xerosis. Proper skin care, including the use of emollients, may help improve xerosis and minimize disease exacerbation. Lactobacillus sakei probio 65, isolated from the Korean vegetable-based product kimchi, can decrease interleukin 4 and immunoglobulin E levels and inhibit Staphylococcus aureus. Moreover, it has reportedly shown positive dermatological effects in both animal and clinical studies.

Objective: To compare the effects of an emollient that contains Lactobacillus (treated) with a normal emollient (control) on AD.

Methods: This double-blind, randomized, split-body clinical trial involved 28 patients with AD. The patients applied the Lactobacillus-containing emollient on one side of their body and the control emollient on the other side twice daily for 4 weeks. Trans-epidermal water loss (TEWL) and skin capacitance were evaluated and investigator global assessment and the visual analogue scale (VAS) were administered on weeks 0, 1, 2, and 4.

Results: The treated sides had significantly lower TEWL and VAS values and significantly higher skin capacitance values over time than the control sides.

Conclusion: Topical application of Lactobacillus-containing emollients may improve the skin permeability of patients with AD.

Keywords: Atopic dermatitis; Emollients; Lactobacillus.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Three groups showed no responses in eye stimulation test (top: PBS, middle: Lactobacillus sakei probio 65 extract containing emollient, bottom: L. sakei probio 65 extract) (A) and skin stimulation test (left: PBS, middle: L. sakei probio 65 extract, right: L. sakei probio 65 extract containing emollient) (B). PBS: phosphate buffer saline.
Fig. 2
Fig. 2
Effect of emollients containing Lactobacillus in atopic dermatitis patients at basline (A) and after 4 weeks (B).
Fig. 3
Fig. 3
Effect of emollients containing Lactobacillus assessed from IGA (A), VAS of pruritus (B), TEWL scores (C), and skin capacitance values of control and treatment sides (D). IGA: investigator's global assessment, VAS: visual analogue scale, TEWL: trans-epidermal water loss.
See this image and copyright information in PMC

References

    1. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151–160. - PubMed
    1. Leung DY, Hanifin JM, Charlesworth EN, Li JT, Bernstein IL, Berger WE, et al. Work Group on Atopic Dermatitis. Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1997;79:197–211. - PubMed
    1. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol. 2004;50:391–404. - PubMed
    1. Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14:321–324. - PubMed
    1. Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol. 2008;19:614–618. - PubMed

LinkOut - more resources